ISE-SHIMA, Japan A British exit from the European Union would be a serious risk to global economic growth, Group of Seven leaders said in a summit declaration on Friday, as Prime Minister David Cameron urged voters to "listen to our friends" on the impact of Brexit.
LONDON The FTSE 100 was set for its biggest weekly gain for six weeks on Friday, trading flat and consolidating recent gains after a sharp rally to a one-month high.
ISE-SHIMA, Japan The Group of Seven industrial powers pledged on Friday to seek strong global growth, while papering over differences on currencies and stimulus policies and expressing concern over North Korea, Russia and maritime disputes involving China.
PARIS Phoenix Group Holdings , Britain's largest owner of life assurance funds closed to new customers, said it would buy French insurer Axa's UK investment and pensions business and its direct protection business.
BENGALURU/BRUSSELS Anglo American Plc's De Beers named insider Bruce Cleaver as chief executive of the diamond group, which the global mining company is counting on to help revive its fortunes.
FRANKFURT Daimler said it will spend 3 billion euros (2.3 billion pounds) to curtail diesel exhaust pollution levels by modifying its engines and exhaust treatment systems including through a software update for some Mercedes-Benz passenger cars.
SINGAPORE/LONDON Oil futures fell below $49 on Friday, easing from a seven-month high hit this week, with analysts predicting range-bound markets for the next few months as supply outages slowly help to clear a global glut of crude.
LONDON Britain's government said on Thursday it had started discussions on overhauling the deficit-laden British Steel Pension Scheme, a major stumbling block for potential buyers of Tata Steel's UK assets.
AUGSBURG, Germany The chief executive of German industrial robot maker Kuka said on Friday he welcomed an impending 4.5 billion- euro (3.43 billion pounds) takeover bid from Chinese home appliance maker Midea.
LONDON AstraZeneca said on Friday U.S. regulators would not approve its new drug for high potassium levels at present due to a manufacturing issue, dealing a blow to a product acquired when it bought ZS Pharma for $2.7 billion (1.8 billion pounds) last year.